- ImmunoCellular Therapeutics (OTCPK:IMUC) promotes SVP of Strategic Resources Anthony Gringeri, Ph.D. to CEO replacing Andrew Gengos who resigned. He joined the company in 2013 from ViaCyte where he was VP and Chief Development Officer.
New chief at ImmunoCellular Therapeutics
Recommended For You
About IMUC Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
IMUC | - | - |
EOM Pharmaceuticals Holdings, Inc. |